Medical Device and Pharmaceutical News
The latest information of interest to regulated industry. Bookmark this page to have a quick review for
-
- FDA enforcement news
- Regulatory updates
- Innovative products
- Compliance information, and
- Other industry headlines.
And do not forget to check our pages for consumer safety information and regulatory services.
FDA Panel to Examine Pathogen-Agnostic Sequencing
November 19 advisory committee meeting will explore the scientific, clinical, and regulatory challenges of diagnostic technologies designed to detect known and potentially unknown pathogens.On November 19, 2026, the U.S. Food and Drug Administration (FDA) will convene...
A New Approach for Infectious-Disease Detection
Pathogen-Agnostic Sequencing and the Future of Infectious Disease PreparednessDetecting the Unknown. Connecting the Signals. Preparing for the Future. What if we could recognize an emerging infectious disease before we knew what pathogen was causing it? Advances in...
FDA Approves Wilserdly for Advanced Breast Cancer
Genentech’s oral estrogen receptor antagonist significantly extends progression-free survival, accompanied by FDA authorization of a liquid biopsy companion diagnostic.On November 16, 2026, the U.S. Food and Drug Administration (FDA) approved giredestrant (Wilserdly,...
FDA Pivots from Artificial Intelligence to Super Intelligence
A Regulatory Solution in Search of a ProblemFDA's implementation of a presidential terminology mandate raises questions about scientific accuracy, regulatory consistency, and the responsible use of limited public health resources.Beginning November 16, 2026, the U.S....
Science, Politics, Special Interests, and FDA Independence
Former Insiders Challenge the Administration's Health AgendaFormer FDA Commissioner Marty Makary and former Kennedy adviser Calley Means allege that political and commercial pressures interfered with federal health priorities. Their accounts raise questions about...
When Preventable Diseases Return
Diseases once brought under control through vaccination have returned with devastating consequences. Historical outbreaks in the former Soviet Union and Japan offer important lessons as the United States confronts its largest measles resurgence in decades.For...
Intersurgical 22mm Smoothbore Breathing Tubes and Systems
FDA Issues Early Alert for Intersurgical Breathing Systems Over Potential Ventilation Failure. Manufacturing defect may cause breathing tube connectors to separate during use, potentially interrupting ventilation and exposing patients to serious injury or death.The...
FDA Early Alert: Teleflex/Arrow Guidewire
Affected guidewires and catheter products may release hydrophilic polymer particles into the bloodstream, potentially causing serious injury or death. No serious injuries or deaths have been reported.The U.S. Food and Drug Administration (FDA) has issued an Early...
Pimicotinib (Pimjetmi) for Tenosynovial Giant Cell Tumor
On November 10, 2026, the Food and Drug Administration approved pimicotinib (Pimjetmi, EMD Serono, Inc.), a kinase inhibitor, for adults with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection may cause worsening functional limitation or...
The Wolverine Peptide Stack: What We Know
Promoted for faster healing and injury recovery, two experimental peptides are attracting growing consumer interest despite limited human clinical evidence and unresolved safety questions.The promise sounds almost too good to be true: faster recovery from injuries,...